Company Description
Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment.
Significant Investors
First Round Capital, Hawktail, Bioverge, SNR, Builders VC, Alumni Ventures, Mount Pleasant Ventures
